Skip to main content

Eagle Asset Management Inc

SEC CIK
0000790502
Latest filing
Nov 12, 2024

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by Eagle Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overviewAll 13F holders of TPTXFull Q3 2024 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
5
Since Q1 2021
Holdings of TPTX by Eagle Asset Management Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−337,609−100.0%Sold outHolders
Q1 2022337,609$9.06M<0.1%−29,228−8.0%ReducedHolders
Q4 2021366,837$17.8M0.1%−30,665−7.7%ReducedHolders
Q3 2021397,502$26.4M0.1%−32,798−7.6%ReducedHolders
Q2 2021430,300$33.6M0.1%+4,427+1.0%AddedHolders
Q1 2021425,873$38.6M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.